ADVERTISEMENT
Activities Discovered for Some Inactive Drug Ingredients
Activities Discovered for Some Inactive Drug Ingredients
Screens of hundreds of drug excipients reveal that some can interact with biological targets, contradicting their FDA categorization as inert.
Activities Discovered for Some Inactive Drug Ingredients
Activities Discovered for Some Inactive Drug Ingredients

Screens of hundreds of drug excipients reveal that some can interact with biological targets, contradicting their FDA categorization as inert.

Screens of hundreds of drug excipients reveal that some can interact with biological targets, contradicting their FDA categorization as inert.

disease & medicine, pharma, drug development

an illustration showing amyloid plaques around brain cells
Biogen Presents Data on Efficacy of Alzheimer’s Drug
Shawna Williams | Dec 6, 2019 | 2 min read
The company and its partner halted two clinical trials for futility early this year, but now say they’ll seek approval for aducanumab.
Serum Survey Reveals Protein Patterns of Ill Health
Ruth Williams | Aug 2, 2018 | 3 min read
Analyses of blood from thousands of people show distinct protein profiles are linked to complex diseases of aging.
ADVERTISEMENT